Separately, Canaccord Genuity increased their target price on shares of Hydropothecary from C$5.25 to C$5.75 in a research report on Thursday, February 15th.
Shares of THCX opened at C$4.27 on Thursday. Hydropothecary has a 52 week low of C$1.10 and a 52 week high of C$5.25.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2018/04/16/hydropothecary-thcx-pt-raised-to-c9-50.html.
Hydropothecary Company Profile
The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.
Receive News & Ratings for Hydropothecary Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydropothecary and related companies with MarketBeat.com's FREE daily email newsletter.